EP4704833A2 - Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen - Google Patents
Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminenInfo
- Publication number
- EP4704833A2 EP4704833A2 EP24798171.5A EP24798171A EP4704833A2 EP 4704833 A2 EP4704833 A2 EP 4704833A2 EP 24798171 A EP24798171 A EP 24798171A EP 4704833 A2 EP4704833 A2 EP 4704833A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- disorder
- minutes
- cycloalkyl
- life
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363576462P | 2023-04-27 | 2023-04-27 | |
| PCT/US2024/026797 WO2024227149A2 (en) | 2023-04-27 | 2024-04-29 | Alkoxy and carbamoyl quaternary amine salts as prodrugs of trpytamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4704833A2 true EP4704833A2 (de) | 2026-03-11 |
Family
ID=93257462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24798171.5A Pending EP4704833A2 (de) | 2023-04-27 | 2024-04-29 | Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4704833A2 (de) |
| WO (1) | WO2024227149A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11759452B2 (en) | 2020-05-08 | 2023-09-19 | Psilera Inc. | Compositions of matter and pharmaceutical compositions |
| JP2024521747A (ja) | 2021-05-25 | 2024-06-04 | アタイ セラピューティクス, インコーポレイテッド | 新しいn,n-ジメチルトリプタミン塩および結晶塩形態 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL295371A (en) * | 2020-02-04 | 2022-10-01 | Mindset Pharma Inc | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders |
| US12017991B2 (en) * | 2021-01-11 | 2024-06-25 | Caamtech, Inc. | Quaternary tryptamines and their therapeutic uses |
| WO2022261383A1 (en) * | 2021-06-09 | 2022-12-15 | ATAI Life Sciences AG | Novel prodrugs and conjugates of dimethyltryptamine |
| EP4137131A1 (de) * | 2021-08-17 | 2023-02-22 | Centre National de la Recherche Scientifique (CNRS) | Neuartige serotonin-analoga und deren verwendungen zur behandlung von eisenassoziierten erkrankungen |
| WO2024118767A2 (en) * | 2022-11-29 | 2024-06-06 | Caamtech, Inc. | Tryptamine derivatives |
-
2024
- 2024-04-29 EP EP24798171.5A patent/EP4704833A2/de active Pending
- 2024-04-29 WO PCT/US2024/026797 patent/WO2024227149A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024227149A3 (en) | 2025-02-06 |
| WO2024227149A2 (en) | 2024-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111818918B (zh) | 用于治疗囊性纤维化的药物组合物 | |
| EP4704833A2 (de) | Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen | |
| CA2744708C (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| TWI537269B (zh) | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘發劑 | |
| ES2666181T3 (es) | Agentes inductores de la apoptosis para el tratamiento del cáncer y de enfermedades inmunitarias y autoinmunitarias | |
| JP5852666B2 (ja) | 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 | |
| WO2019191620A1 (en) | Crystalline forms of modulators of cftr | |
| WO2017114509A1 (zh) | 醛基类化合物及其制法和用途 | |
| EP3508481A1 (de) | Kristalline form von ozanimodhydrochlorid und herstellungsverfahren dafür | |
| CN110088092A (zh) | 化合物,获得化合物的方法,药物组合物,化合物的用途和治疗精神障碍和/或睡眠障碍的方法 | |
| AU2019265011B2 (en) | Inhibitors of the RAS oncoprotein, methods of making and methods of use thereof | |
| CN113549073B (zh) | 作为JAK抑制剂的吡唑并[1,5-a]嘧啶衍生物 | |
| JP7628252B2 (ja) | 二環式ピリジン組成物およびがんの治療にそれを使用する方法 | |
| TW201922690A (zh) | 環-amp反應元素結合蛋白的抑制劑 | |
| CN105566302B (zh) | 二氢吲哚酮化合物及其盐的结晶 | |
| CA3176727A1 (en) | Antiviral 1,3-di-oxo-indene compounds | |
| WO2021184958A1 (zh) | 血管生成抑制剂、其制备方法和应用 | |
| CN120424027B (zh) | 一种伏硫西汀半帕莫酸盐晶型 | |
| EP3781568A1 (de) | Ponatinibform | |
| TW202104216A (zh) | Plk4抑制劑之結晶型 | |
| CN100569740C (zh) | N-or酰胺类化合物,其制备方法和其应用 | |
| CN116120254B (zh) | 13,14-双一氧化氮供体-β-榄香烯衍生物及其制备和应用 | |
| CN112759583B (zh) | 包含呋喃基的喹啉类衍生物及其制备方法和用途 | |
| TW200307548A (en) | Histamine-3 receptor ligands for diabetic conditions | |
| CN103772374B (zh) | 一种杂环类化合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251027 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |